Related Experiment Videos

The quantitative histochemistry of multiple sclerosis plaques: acid proteinase and other acid hydrolases

H E Hirsch, P Duquette, M E Parks

Journal of Neurochemistry

|March 1, 1976

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Multiple sclerosis disability progression and predictors: A retrospective cohort study over five decades from a Canadian registry.

Revue neurologique·2026

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal of medical economics·2023

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022

The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis.

Current medical research and opinion·2019

Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.

European journal of neurology·2018

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.

European journal of neurology·2016

See all related articles